Corifollitropin alfa

Generic Name
Corifollitropin alfa
Brand Names
Elonva
Drug Type
Biotech
Chemical Formula
-
CAS Number
195962-23-3
Unique Ingredient Identifier
T7K20Y2GWY
Background

Corifollitropin alfa, also known as Elonva is used in women undergoing fertility treatment to stimulate the development of more than one mature egg (oocyte) at a time in the ovaries. This drug used together with a gonadotropin-releasing hormone (GnRH) antagonist, a type of medicine also used in fertility treatments. Elonva is available only by prescription ....

Indication

Controlled ovarian stimulation in cases of women who are undergoing fertility treatment to stimulate the development of more than one mature egg simultaneously in the ovaries in combination with a gonadotrophin-releasing hormone (GnRH) antagonist (a type of medicine also used in fertility treatments).

Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone (FSH) in Ovarian Stimulation of Women Undergoing in Vitro Fertilisation

First Posted Date
2011-03-22
Last Posted Date
2021-03-17
Lead Sponsor
National and Kapodistrian University of Athens
Target Recruit Count
140
Registration Number
NCT01319695
Locations
🇬🇷

3rd Department of Obstetrics and Gynecology, Assisted Reproduction Unit, Athens, Chaidari, Greece

🇬🇷

Attikon University Hospital, Athens, Chaidari, Greece

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05693 (P05713)

First Posted Date
2008-06-20
Last Posted Date
2022-02-03
Lead Sponsor
Organon and Co
Target Recruit Count
1
Registration Number
NCT00702338

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05714 (Care Program)(P05715)

First Posted Date
2008-06-20
Last Posted Date
2022-02-03
Lead Sponsor
Organon and Co
Target Recruit Count
268
Registration Number
NCT00702234

Follow-up Protocol on the Outcome of Frozen-thawed Embryo Transfer Cycles From Clinical Trial P05690 (P05711)

First Posted Date
2008-06-20
Last Posted Date
2022-02-03
Lead Sponsor
Organon and Co
Target Recruit Count
102
Registration Number
NCT00702546

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05690 (Care Program) (P05710)

First Posted Date
2008-06-20
Last Posted Date
2022-02-03
Lead Sponsor
Organon and Co
Target Recruit Count
113
Registration Number
NCT00702624

Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)

First Posted Date
2008-06-13
Last Posted Date
2024-06-18
Lead Sponsor
Organon and Co
Target Recruit Count
682
Registration Number
NCT00696878

A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)

First Posted Date
2008-06-13
Last Posted Date
2024-06-20
Lead Sponsor
Organon and Co
Target Recruit Count
1509
Registration Number
NCT00696800

A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693)

First Posted Date
2008-06-13
Last Posted Date
2024-06-17
Lead Sponsor
Organon and Co
Target Recruit Count
8
Registration Number
NCT00697255

A Phase 2, Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian (Study 38826)(P06055)(COMPLETED)

First Posted Date
2008-01-21
Last Posted Date
2024-08-15
Lead Sponsor
Organon and Co
Target Recruit Count
325
Registration Number
NCT00598208
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy